Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 3
2004 1
2005 2
2006 5
2007 2
2008 6
2009 7
2010 1
2011 7
2012 5
2013 3
2014 5
2015 2
2016 6
2017 4
2018 3
2019 3
2020 2
2021 5
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
α-L-iduronidase fused with humanized anti-human transferrin receptor antibody (lepunafusp alfa) for mucopolysaccharidosis type I: A phase 1/2 trial.
Harmatz P, Giugliani R, Martins AM, Hamazaki T, Kubo T, Kira R, Minami K, Ikeda T, Moriuchi H, Kawashima S, Takasao N, So S, Sonoda H, Hirato T, Tanizawa K, Schmidt M, Sato Y. Harmatz P, et al. Among authors: ikeda t. Mol Ther. 2024 Mar 6;32(3):609-618. doi: 10.1016/j.ymthe.2024.01.009. Epub 2024 Jan 10. Mol Ther. 2024. PMID: 38204164 Free article. Clinical Trial.
Lanthanide and Actinide Ion Complexes Containing Organic Ligands Investigated by Surface-Enhanced Infrared Absorption Spectroscopy.
Hirata S, Kusaka R, Meiji S, Tamekuni S, Okudera K, Hamada S, Sakamoto C, Honda T, Matsushita K, Muramatsu S, Ebata T, Kajiya D, Saitow KI, Ikeda T, Hirao T, Haino T, Watanabe M, Inokuchi Y. Hirata S, et al. Among authors: ikeda t. Inorg Chem. 2023 Jan 9;62(1):474-486. doi: 10.1021/acs.inorgchem.2c03618. Epub 2022 Dec 22. Inorg Chem. 2023. PMID: 36548946
Pharmacokinetics and pharmacodynamics of once-weekly administration of JR-142, a long-acting albumin-fused human growth hormone: A rondemized, placebo-controlled phase 1 study.
Owada Y, Okazaki M, Ikeda T, Yamamoto R, Minami K, Takahashi K, Hirato T, Mita Y, Yamamoto T, Tanizawa K, Sonoda H, Sato Y. Owada Y, et al. Among authors: ikeda t. Growth Horm IGF Res. 2022 Dec;67:101500. doi: 10.1016/j.ghir.2022.101500. Epub 2022 Sep 8. Growth Horm IGF Res. 2022. PMID: 36113378 Free article. Clinical Trial.
A Thrombomodulin Promoter Gene Polymorphism, rs2239562, Influences Both Susceptibility to and Outcome of Sepsis.
Watanabe E, Takasu O, Teratake Y, Sakamoto T, Ikeda T, Kotani J, Kitamura N, Ohmori M, Teratani A, Honda G, Hatano M, Mayer B, Schneider EM, Oda S. Watanabe E, et al. Among authors: ikeda t. Front Med (Lausanne). 2022 Jan 10;8:762198. doi: 10.3389/fmed.2021.762198. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35083232 Free PMC article.
Enzyme Replacement Therapy with Pabinafusp Alfa for Neuronopathic Mucopolysaccharidosis II: An Integrated Analysis of Preclinical and Clinical Data.
Giugliani R, Martins AM, Okuyama T, Eto Y, Sakai N, Nakamura K, Morimoto H, Minami K, Yamamoto T, Yamaoka M, Ikeda T, So S, Tanizawa K, Sonoda H, Schmidt M, Sato Y. Giugliani R, et al. Among authors: ikeda t. Int J Mol Sci. 2021 Oct 10;22(20):10938. doi: 10.3390/ijms222010938. Int J Mol Sci. 2021. PMID: 34681597 Free PMC article.
70 results